Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Alison Sathe
Anders Vinther
Barbara W. Unger
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Mark Agostino
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Trends

FINAL Part 3: Invisible Ink in GLP and GCP Research

No items found.

The New FDA GMP Inspection Model

No items found.
Trends

Part 2: Invisible Ink in GLP and GCP Research

No items found.
Trends

Part 3: Drug GMP Warning Letters Data Integrity

No items found.
Trends

Part 1: Invisible Ink in GLP and GCP Research

No items found.
Trends

Part 2: Drug GMP Warning Letters Data Integrity

No items found.
Trends

Follow the Trail to Find Data Integrity Problems

No items found.

Who Can See Form FDA 483s, and Where Do I Get Them?

No items found.
Trends

Part 1: Drug GMP Warning Letters Data Integrity

No items found.
Trends

How Do I Apply ALCOA To E-Records?

No items found.
Enforcement

Part 1: FDA and MHRA’s Drug Inspection Observations

No items found.
Trends

The Secret Life of (b)s

No items found.
Trends

A Look Into the Foreign Food Facility Inspection Program

No items found.

3 Strategies to Monitor 1,000+ Suppliers

No items found.

Deep Dive into FSMA Foreign Supplier Verification: 5 Pitfalls to Avoid

No items found.

The FDA’s “One Quality Voice”

No items found.

What Can Mid-Sized Food Companies Learn About FSMA from the Big Shots?

No items found.
Trends

CDRH Planned Reorganization Breaks Down Silos and Focuses Expertise by Product Type

No items found.